Bronchopulmonary Penetration of Isavuconazole in Pulmonary Transplant Recipients (PBISA01): Protocol for a Phase IV Clinical Trial With a Single Treatment Arm

BACKGROUND: Aspergillosis is the most frequently observed invasive fungal disease (IFD) in lung transplant recipients. Isavuconazole (ISA) has shown a better safety profile and noninferiority to voriconazole in the treatment of patients with IFD. OBJECTIVE: The aim of this study is to describe the b...

Descripción completa

Detalles Bibliográficos
Autores principales: Darnaude-Ximénez, Ignacio, Caballero-Bermejo, Antonio F, Ruiz-Antorán, Belén, Aguilar-Pérez, Myriam, Gómez-López, Alicia, Sancho-López, Aranzazu, García-Fadul, Cristian, Diago-Sempere, Elena, Valle Falcones, Manuel, Ussetti-Gil, Piedad, Avendaño-Solá, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520388/
https://www.ncbi.nlm.nih.gov/pubmed/36103230
http://dx.doi.org/10.2196/37275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520388/
https://www.ncbi.nlm.nih.gov/pubmed/36103230
http://dx.doi.org/10.2196/37275

Ejemplares similares